The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.00
Bid: 135.80
Ask: 136.20
Change: -0.10 (-0.07%)
Spread: 0.40 (0.295%)
Open: 137.40
High: 137.60
Low: 134.30
Prev. Close: 136.10
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Aston Martin Lagonda and Mercedes-Benz AG

26 Jun 2023 07:00

RNS Number : 8151D
Aston Martin Lagonda Glob.Hldgs PLC
26 June 2023
 

26 June 2023

 

Aston Martin Lagonda Global Holdings plc

 

Aston Martin Lagonda and Mercedes-Benz AG announce amendment and restatement of Strategic Co-operation Agreement

 

· Aston Martin and Mercedes-Benz AG to continue long-term strategic co-operation, supporting the delivery of current and future generation Aston Martin vehicles

· Amendment and restatement of the Strategic Co-operation Agreement ("SCA") will see the original agreement to issue additional Aston Martin shares to Mercedes-Benz in exchange for access to further technology replaced with a restated commitment to the existing strategic collaboration allowing the parties to discuss future access to technology for cash

· No further consideration shares, or related cash top up payments, will be issued or paid to Mercedes-Benz under the SCA

· Mercedes-Benz to remain a long-term strategic partner and c.9% shareholder in Aston Martin and to retain current representation on the Aston Martin Board of Directors

Aston Martin Lagonda Global Holdings plc ("Aston Martin", "Aston Martin Lagonda" or the "Company") and Mercedes-Benz AG) ("MBAG" or "Mercedes") today announce that they have agreed to amend and restate the Strategic Co-operation Agreement ("SCA"), originally entered into on 27 October 2020.

As previously announced by the Company, the SCA provided the Company with access to a wide range of MBAG's technology, in consideration for which Aston Martin agreed to issue consideration shares in at least two tranches by no later than July 2024. The second of these tranches currently remains unissued. The amendment agreed between the parties today will see the agreement to issue this second tranche of consideration shares replaced with a restated commitment to the existing strategic collaboration between Aston Martin and MBAG in connection with the potential future supply of MBAG technology to Aston Martin, payable for in cash.

Mercedes-Benz AG will continue to provide Aston Martin with access to a range of world-class technologies, including powertrain and electric/electronic architectures for current and future generation Aston Martin vehicles, including internal combustion engine, hybrid and electric vehicles.

Underscoring the continued long-term partnership between the Company and MBAG, the Relationship Agreement entered into between them on 27 October 2020 will remain in place, in accordance with which MBAG will retain representation on the Aston Martin Board of Directors. MBAG likewise preserves its shareholding in the Company, which on the date of this announcement represents approximately 9.4% of the Company's issued share capital.

The Company also this morning separately announces its intention to form a strategic supply agreement with Lucid Group, Inc. ("Lucid") to provide Aston Martin with access to Lucid's industry-leading technology for Aston Martin's battery electric vehicles. As part of the amendment and restatement of the SCA, MBAG has waived any rights or obligations (including any termination rights) under the SCA that may have otherwise arisen in connection with the proposed partnership with Lucid.

Lawrence Stroll, Executive Chairman of Aston Martin, said: "I am delighted to continue our long-term partnership with Mercedes-Benz and appreciate their ongoing support of Aston Martin. This amendment provides clarity and will see both companies continue our long-standing relationship, providing us with access to Mercedes' world-class technologies as we bring our new range of breathtaking products to market over the coming years."

Franz Reiner, Non-Executive Director and Mercedes-Benz AG Representative, said: "As a long-term shareholder, Mercedes-Benz supports Aston Martin's future development as an independent luxury carmaker. Today's revised cooperation agreement is the best of both worlds: It ensures that Aston Martin continues to have access to a wide range of Mercedes-Benz technologies, while at the same time giving the iconic British carmaker the opportunity to explore new opportunities which fit its specific needs."

 

Regulatory Disclosures

This announcement includes inside information as defined in Article 7 of the UK Market Abuse Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 and is being released on behalf of the Company by Liz Miles, Company Secretary.

Enquiries

Investors and Analysts

Sherief Bakr

Director of Investor Relations

+44 (0)7789 177547sherief.bakr@astonmartin.com

 

Holly Grainger

Deputy Head, Investor Relations

+44 (0)7442 989551holly.grainger@astonmartin.com

 

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683kevin.watters@astonmartin.com

 

Paul Garbett

Head of Corporate and Brand Communications

 

+44 (0)7501 380799paul.garbett@astonmartin.com

 

Edward Taylor

 

Head of Business and Finance Communications, Mercedes-Benz Group AG

 

 

+49 176 3094 1776

edward.taylor@mercedes-benz.com

Teneo

Harry Cameron

 

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUVOAROOUNUUR
Date   Source Headline
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20224:38 pmRNSHolding(s) in Company
14th Sep 20229:49 amRNSHolding(s) in Company
14th Sep 20229:46 amRNSHolding(s) in Company
14th Sep 20227:00 amRNSRights Issue offer period amended
13th Sep 20229:00 amRNSHolding(s) in Company
12th Sep 20227:00 amRNSAdmission of Nil Paid Rights
9th Sep 20227:00 amRNSAdmission of placing shares & total voting rights
8th Sep 202211:32 amRNSResult of General Meeting
5th Sep 202212:28 pmRNSPublication of Prospectus
5th Sep 20227:00 amRNS4 for 1 c.£575.8 million Rights Issue
22nd Aug 20227:00 amRNSCircular and Notice of General Meeting
29th Jul 20227:00 amRNSHalf-year Report
15th Jul 20227:00 amRNSProposed New Equity Financing and Investment
1st Jul 20223:37 pmRNSHolding(s) in Company
1st Jul 202211:38 amRNSHolding(s) in Company
30th Jun 20223:31 pmRNSStatement Regarding Media Commentary
20th Jun 20221:20 pmRNSCompany Secretary Change
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
25th May 202212:04 pmRNSResult of AGM
11th May 20227:00 amRNSHolding(s) in Company
4th May 20227:01 amRNS1st Quarter Results
4th May 20227:00 amRNSAppointment of New Chief Executive Officer
3rd May 20227:00 amRNSNew Chief Financial Officer Joins Board
28th Apr 20223:14 pmRNSHolding(s) in Company
25th Apr 20222:08 pmRNSNotice of AGM
20th Apr 202212:19 pmRNSDirector Declaration
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:02 amRNSChief Financial Officer Board Appointment Date
14th Mar 20227:00 amRNSPublication of 2021 Annual Report and Accounts
28th Feb 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSDirectorate Change
7th Jan 20227:00 amRNSFY 2021 Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 202110:01 amRNSDirector/PDMR Shareholding
2nd Dec 20213:07 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirectorate Change
1st Dec 202110:19 amRNSAdditional Listing
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 202110:30 amRNSDirector/PDMR Shareholding
8th Nov 202110:49 amRNSDirector/PDMR Shareholding
4th Nov 20217:05 amRNSResults for the nine months to 30 September 2021
29th Oct 202110:02 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.